Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia A pilot study

doi:10.3748/wjg.v10.i4.586

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2741)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

270

HTML

2140

Figures (1-3)

187

Tables (1-1)

144

Sum=2741

Feb 15, 2004 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 15, 2004; 10(4): 586-589
Published online Feb 15, 2004. doi: 10.3748/wjg.v10.i4.586

Full Size Figure Download Figure

Figure 3 Box-and-whisker plots showing haematocrit values over the recovery period from peptic ulcer bleeding of patients treated with Epoetin alfa plus iron (G₁, dashed whiskers) and those treated with iron only (G₂, open whiskers). On day four-teen patients in G₁ had significantly different (higher) haematocrit values as compared with G₂ (two-tailed Mann-Whitney U test = 49.0, P = 0.041).

Citation: Ladas SD, Polymeros D, Pagonis T, Triantafyllou K, Paspatis G, Hatziargiriou M, Raptis SA. Does recombinant human erythropoietin accelerate correction of post-ulcer-bleeding anaemia A pilot study. World J Gastroenterol 2004; 10(4): 586-589
URL: https://www.wjgnet.com/1007-9327/full/v10/i4/586.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i4.586